Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

RUNX3 expression correlates with chief cell differentiation in human gastric cancers.

N Ogasawara1, T Tsukamoto, T Mizoshita

  • 1Division of Oncological Pathology, Aichi Cancer Center Research Institute, Chikusa-ku, Nagoya, Japan.

Histology and Histopathology
|November 18, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Examination of the potential clinical application of 5DEX-0509R, the tumor macrophage-targeting nanomedicine.

Cytokine·2024
Same author

Letter: a potassium-competitive acid blocker vs a proton pump inhibitor for healing endoscopic submucosal dissection-induced artificial ulcers after treatment of gastric neoplasms.

Alimentary pharmacology & therapeutics·2017
Same author

Letter: CYP3A4/5 genotype status and outcome of vonoprazan-containing Helicobacter pylori eradication therapy in Japan.

Alimentary pharmacology & therapeutics·2017
Same author

Fiber-based modulated optical reflectance configuration allowing for offset pump and probe beams.

The Review of scientific instruments·2017
Same author

Infarcted intestinal volvulus detected by prenatal ultrasonography.

Pediatric surgery international·2013
Same author

Neuroradiologic features in X-linked α-thalassemia/mental retardation syndrome.

AJNR. American journal of neuroradiology·2013

RUNX3, a tumor suppressor, is linked to pepsinogen I expression in gastric cancers. This study shows RUNX3 maintains chief cell phenotype in normal and cancerous gastric tissues.

Area of Science:

  • Gastroenterology
  • Oncology
  • Cell Biology

Background:

  • RUNX3 acts as a tumor suppressor in gastric cancer.
  • RUNX3 is crucial for chief cell differentiation in the gastric fundic mucosa.

Purpose of the Study:

  • To investigate the relationship between RUNX3 expression and differentiation markers in gastric cancer.
  • To confirm RUNX3's role in chief cell phenotype maintenance.

Main Methods:

  • Immunohistochemistry was used to analyze RUNX3 expression in 102 gastric cancer tissues.
  • Histological assessment of differentiation markers, including pepsinogen I, MUC5AC, and MUC6, was performed.

Main Results:

  • RUNX3 expression was detected in the fundic gland but minimally in surface mucous cells.

Related Experiment Videos

  • RUNX3 positivity was observed in 45 out of 102 gastric cancers.
  • RUNX3 expression significantly correlated with pepsinogen I expression (P<0.001), indicating an association with chief cell phenotype.

    • Conclusions:

    • RUNX3 is strongly associated with chief cell phenotypic expression in human gastric cancers.
    • RUNX3 plays a significant role in maintaining the chief cell phenotype in both normal and cancerous gastric mucosa.
    • The study establishes a novel link between RUNX3 and pepsinogen I in gastric carcinogenesis.